Manchester Collaborative Centre for Inflammation Research (MCCIR)
At a Glance
- Status: Active Consortium
- Year Launched: 2012
- Initiating Organization: University of Manchester
- Initiator Type: Academia
- Disease focus:
- Location: Europe
The Manchester Collaborative Centre for Inflammation Research (MCCIR) was established to address current priorities in inflammatory disease in an open innovation, precompetitive collaboration between academia and the pharmaceutical industry.
MCCIR’s mission is to bring together clinical, industrial, and academic scientists – and innovate at this interface or in this unique interactive environment.
The following are MCCIR characteristics:
2012: MCCIR established
GlaxoSmithKline, AstraZeneca, and the University of Manchester have each invested £5 million.
Sponsors & Partners
University of Manchester